[en] This review explores various aspects of the interaction between microtubule targeting agents and tubulin, including binding site, affinity, and drug resistance. Starting with the basics of tubulin polymerization and microtubule targeting agent binding, we then highlight how the three-dimensional structures of drug-tubulin complexes obtained on stabilized tubulin are seeded by precise biological and biophysical data. New avenues opened by thermodynamics analysis, high throughput screening, and proteomics for the molecular pharmacology of these drugs are presented. The amount of data generated by biophysical, proteomic and cellular techniques shed more light onto the microtubule-tubulin equilibrium and tubulin-drug interaction. Combining these approaches provides new insight into the mechanism of action of known microtubule interacting agents and rapid in-depth characterization of next generation molecules targeting the interaction between microtubules and associated modulators of their dynamics. This will facilitate the design of improved and/or alternative chemotherapies targeting the microtubule cytoskeleton.
Disciplines :
Oncology
Author, co-author :
Calligaris, David ; Université de Liège - ULiège > Département de chimie (sciences) > GIGA-R : Laboratoire de spectrométrie de masse (L.S.M.)
Verdier-Pinard, Pascal
Devred, François
Villard, Claude
Braguer, Diane
Lafitte, Daniel
Language :
English
Title :
Microtubule targeting agents: from biophysics to proteomics
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Bryan J, Wilson L (1971) Are cytoplasmic microtubules heteropolymers? Proc Natl Acad Sci USA 68:1762-1766
Akhmanova A, Steinmetz MO (2008) Tracking the ends: a dynamic protein network controls the fate of microtubule tips. Nat Rev Mol Cell Biol 9:309-322 (Pubitemid 351430849)
Nogales E, Wang HW (2006) Structural intermediates in microtubule assembly and disassembly: how and why? Curr Opin Cell Biol 18:179-184
Ballestrem C, Magid N, Zonis J, Shtutman M, Bershadsky A (2004) Interplay between the actin cytoskeleton, focal adhesions, and microtubules. In: Ridley A, Peckham M, Clark P (eds) Cell motility. From molecules to organisms. Wiley, Chichester, pp 75-99
Vasiliev JM, Gelfand IM, Domnina LV, Ivanova OY, Komm SG, Olshevskaja LV (1970) Effect of colcemid on the locomotory behaviour of fibroblasts. J Embryol Exp Morphol 24:625-640
Kline-Smith SL, Walczak CE (2004) Mitotic spindle assembly and chromosome segregation: refocusing on microtubule dynamics. Mol Cell 15:317-327 (Pubitemid 39092749)
Wittmann T, Hyman A, Desai A (2001) The spindle: a dynamic assembly of microtubules and motors. Nat Cell Biol 3:E28-E34 (Pubitemid 32114823)
Hill TL, Chen Y (1984) Phase changes at the end of a microtubule with a GTP cap. Proc Natl Acad Sci USA 81:5772-5776
Wilson L, Panda D, Jordan MA (1999) Modulation of microtubule dynamics by drugs: a paradigm for the actions of cellular regulators. Cell Struct Funct 24:329-335
Rowinsky EK, Calvo E (2006) Novel agents that target tublin and related elements. Semin Oncol 33:421-435
Parness J, Horwitz SB (1981) Taxol binds to polymerized tubulin in vitro. J Cell Biol 91:479-487 (Pubitemid 12215635)
Derry WB, Wilson L, Jordan MA (1995) Substoichiometric binding of taxol suppresses microtubule dynamics. Biochemistry 34:2203-2211
Dhamodharan R, Jordan MA, Thrower D, Wilson L, Wadsworth P (1995) Vinblastine suppresses dynamics of individual microtubules in living interphase cells. Mol Biol Cell 6:1215-1229
Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I (1987) Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84:265-269 (Pubitemid 17013615)
Nogales E, Wolf SG, Downing KH (1998) Structure of the alpha beta tubulin dimer by electron crystallography. Nature 391:199-203 (Pubitemid 28092482)
Lowe J, Li H, Downing KH, Nogales E (2001) Refined structure of alpha beta-tubulin at 3.5 A resolution. J Mol Biol 313:1045-1057 (Pubitemid 33081900)
Panda D, Miller HP, Banerjee A, Luduena RF, Wilson L (1994) Microtubule dynamics in vitro are regulated by the tubulin isotype composition. Proc Natl Acad Sci USA 91:11358-11362 (Pubitemid 24356343)
Billger MA, Bhattacharjee G, Williams RC Jr (1996) Dynamic instability of microtubules assembled from microtubule-associated protein-free tubulin: neither variability of growth and shortening rates nor "rescue" requires microtubule-associated proteins. Biochemistry 35:13656-13663
Joshi HC (1998) Microtubule dynamics in living cells. Curr Opin Cell Biol 10:35-44
Oakley CE, Oakley BR (1989) Identification of gamma-tubulin, a new member of the tubulin superfamily encoded by mipA gene of Aspergillus nidulans. Nature 338:662-664
Moritz M, Braunfeld MB, Guenebaut V, Heuser J, Agard DA (2000) Structure of the gamma-tubulin ring complex: a template for microtubule nucleation. Nat Cell Biol 2:365-370
Keating TJ, Borisy GG (2000) Immunostructural evidence for the template mechanism of microtubule nucleation. Nat Cell Biol 2:352-357
Job D, Valiron O, Oakley B (2003) Microtubule nucleation. Curr Opin Cell Biol 15:111-117
Oakley BR (2000) An abundance of tubulins. Trends Cell Biol 10:537-542
Dutcher SK (2001) The tubulin fraternity: alpha to eta. Curr Opin Cell Biol 13:49-54
McKean PG, Vaughan S, Gull K (2001) The extended tubulin superfamily. J Cell Sci 114:2723-2733
Verdier-Pinard P, Pasquier E, Xiao H, Burd B, Villard C, Lafitte D, Miller LM, Angeletti RH, Horwitz SB, Braguer D (2009) Tubulin proteomics: towards breaking the code. Anal Biochem 384:197-206
Verdier-Pinard P, Wang F, Burd B, Angeletti RH, Horwitz SB, Orr GA (2003) Direct analysis of tubulin expression in cancer cell lines by electrospray ionization mass spectrometry. Biochemistry 42:12019-12027 (Pubitemid 37280652)
Al-Bassam J, van Breugel M, Harrison SC, Hyman A (2006) Stu2p binds tubulin and undergoes an open-to-closed conformational change. J Cell Biol 172:1009-1022
Brouhard GJ, Stear JH, Noetzel TL, Al-Bassam J, Kinoshita K, Harrison SC, Howard J, Hyman AA (2008) XMAP215 is a processive microtubule polymerase. Cell 132:79-88
Mozziconacci J, Sandblad L, Wachsmuth M, Brunner D, Karsenti E (2008) Tubulin dimers oligomerize before their incorporation into microtubules. PLoS One 3:e3821
Kerssemakers JW, Munteanu EL, Laan L, Noetzel TL, Janson ME, Dogterom M (2006) Assembly dynamics of microtubules at molecular resolution. Nature 442:709-712 (Pubitemid 44215328)
Braguer D, Barret JM, McDaid H, Kruczynski A (2008) Antitumor activity of vinflunine: effector pathways and potential for synergies. Semin Oncol 35:S13-S21 (Pubitemid 351758953)
Pourroy B, Honoré S, Pasquier E, Bourgarel-Rey V, Kruczynski A, Briand C, Braguer D (2006) Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cells. Cancer Res 66:3256-3263
Nettles JH, Li H, Cornett B, Krahn JM, Snyder JP, Downing KH (2004) The binding mode of epothilone A on alpha, beta-tubulin by electron crystallography. Science 305:866-869 (Pubitemid 39038421)
Pryor DE, O'Brate A, Bilcer G, Diaz JF, Wang Y, Kabaki M, Jung MK, Andreu JM, Ghosh AK, Giannakakou P, Hamel E (2002) The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity. Biochemistry 41:9109-9115 (Pubitemid 34787268)
Gaitanos TN, Buey RM, Diaz JF, Northcote PT, TeesdaleSpittle P, Andreu JM, Miller JH (2004) Peloruside A does not bind to the taxoid site on beta-tubulin and retains its activity in multidrug-resistant cell lines. Cancer Res 64:5063-5067
Terkeltaub R (2005) Pathogenesis and treatment of crystalinduced inflammation. In: Koopman WJ, Moreland LW (eds) Arthritis and allied aconditions, 15th edn. Lippincott Williams and Wilkins, Philadelphia, pp 2357-2372
Gigant B, Wang C, Ravelli RB, Roussi F, Steinmetz MO, Curmi PA, Sobel A, Knossow M (2005) Structural basis for the regulation of tubulin by vinblastine. Nature 435:519-522 (Pubitemid 40734250)
Andreu JM, Barasoain I (2001) The interaction of baccatin III with the taxol binding site of microtubules determined by a homogeneous assay with fluorescent taxoid. Biochemistry 40:11975-11984
Rao S, He L, Chakravarty S, Ojima I, Orr GA, Horwitz SB (1999) Characterization of the Taxol binding site on the microtubule. Identification of Arg(282) in beta-tubulin as the site of photoincorporation of a 7-benzophenone analogue of Taxol. J Biol Chem 274:37990-37994 (Pubitemid 30026868)
Rao S, Horwitz SB, Ringel I (1992) Direct photoaffinity labeling of tubulin with taxol. J Natl Cancer Inst 84:785-788
Carboni JM, Farina V, Rao S, Hauck SI, Horwitz SB, Ringel I (1993) Synthesis of a photoaffinity analog of taxol as an approach to identify the taxol binding site on microtubules. J Med Chem 36:513-515 (Pubitemid 23065312)
Paik Y, Yang C, Metaferia B, Tang S, Bane S, Ravindra R, Shanker N, Alcaraz AA, Johnson SA, Schaefer J, O'Connor RD, Cegelski L, Snyder JP, Kingston DG (2007) Rotational-echo double-resonance NMR distance measurements for the tubulinbound Paclitaxel conformation. J Am Chem Soc 129:361-370 (Pubitemid 46106636)
Han Y, Malak H, Chaudhary AG, Chordia MD, Kingston DG, Bane S (1998) Distances between the paclitaxel, colchicine, and exchangeable GTP binding sites on tubulin. Biochemistry 37:6636-6644 (Pubitemid 28228097)
Xiao H, Verdier-Pinard P, Fernandez-Fuentes N, Burd B, Angeletti R, Fiser A, Horwitz SB, Orr GA (2006) Insights into the mechanism of microtubule stabilization by Taxol. Proc Natl Acad Sci USA 103:10166-10173 (Pubitemid 44051138)
Huzil JT, Chik JK, Slysz GW, Freedman H, Tuszynski J, Taylor RE, Sackett DL, Schriemer DC (2008) A unique mode of microtubule stabilization induced by peloruside A. J Mol Biol 378:1016-1030
Kowalski RJ, Giannakakou P, Gunasekera SP, Longley RE, Day BW, Hamel E (1997) The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells. Mol Pharmacol 52:613-622 (Pubitemid 27443983)
Keskin O, Durell SR, Bahar I, Jernigan RL, Covell DG (2002) Relating molecular flexibility to function: a case study of tubulin. Biophys J 83:663-680 (Pubitemid 34803607)
Jimenez-Barbero J, Amat-Guerri F, Snyder JP (2002) The solid state, solution and tubulin-bound conformations of agents that promote microtubule stabilization. Curr Med Chem Anticancer Agents 2:91-122 (Pubitemid 34649870)
Xia S, Kenesky CS, Rucker PV, Smith AB 3rd, Orr GA, Horwitz SB (2006) A photoaffinity analogue of discodermolide specifically labels a peptide in beta-tubulin. Biochemistry 45:11762-11775 (Pubitemid 44497804)
Madiraju C, Edler MC, Hamel E, Raccor BS, Balachandran R, Zhu G, Giuliano KA, Vogt A, Shin Y, Fournier JH, Fukui Y, Brückner AM, Curran DP, Day BW (2005) Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin. Biochemistry 44:15053-15063 (Pubitemid 41612284)
Buey RM, Calvo E, Barasoain I, Pineda O, Edler MC, Matesanz R, Cerezo G, Vanderwal CD, Day BW, Sorensen EJ, Lopez JA, Andreu JM, Hamel E, Díaz JF (2007) Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites. Nat Chem Biol 3:117-125 (Pubitemid 46134999)
Hamel E, Day BW, Miller JH, Jung MK, Northcote PT, Ghosh AK, Curran DP, Cushman M, Nicolaou KC, Paterson I, Sorensen EJ (2006) Synergistic effects of peloruside A and laulimalide with taxoid site drugs, but not with each other, on tubulin assembly. Mol Pharmacol 70:1555-1564
Wilmes A, Bargh K, Kelly C, Northcote PT, Miller JH (2007) Peloruside A synergizes with other microtubule stabilizing agents in cultured cancer cell lines. Mol Pharm 4:269-280
Prakash V, Timasheff SN (1991) Mechanism of interaction of vinca alkaloids with tubulin: catharanthine and vindoline. Biochemistry 30:873-880
Safa AR, Hamel E, Felsted RL (1987) Photoaffinity labeling of tubulin subunits with a photoactive analogue of vinblastine. Biochemistry 26:97-102
Rai SS, Wolff J (1996) Localization of the vinblastine-binding site on beta-tubulin. J Biol Chem 271:14707-14711
Barbier P, Gregoire C, Devred F, Sarrazin M, Peyrot V (2001) In vitro effect of cryptophycin 52 on microtubule assembly and tubulin: molecular modeling of the mechanism of action of a new antimitotic drug. Biochemistry 40:13510-13519
Cormier A, Marchand M, Ravelli RB, Knossow M, Gigant B (2008) Structural insight into the inhibition of tubulin by vinca domain peptide ligands. EMBO Rep 9:1101-1106
Bai RL, Paull KD, Herald CL, Malspeis L, Pettit GR, Hamel E (1991) Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data. J Biol Chem 266:15882-15889
Schmitt H, Atlas D (1976) Specific affinity labelling of tubulin with bromocolchicine. J Mol Biol 102:743-758
Williams RF, Mumford CL, Williams GA, Floyd LJ, Aivaliotis MJ, Martinez RA, Robinson AK, Barnes LD (1985) A photoaffinity derivative of colchicine: 6′-(4′-azido-2′-nitrophenylamino) hexanoyldeacetylcolchicine. Photolabeling and location of the colchicine-binding site on the alpha-subunit of tubulin. J Biol Chem 260:13794-13802
Grover S, Boye O, Getahun Z, Brossi A, Hamel E (1992) Chloroacetates of 2- and 3-demethylthiocolchicine: specific covalent interactions with tubulin with preferential labeling of the beta-subunit. Biochem Biophys Res Commun 187:1350-1358
Lin CM, Ho HH, Pettit GR, Hamel E (1989) Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin. Biochemistry 28:6984-6991
Floyd LJ, Barnes LD, Williams RF (1989) Photoaffinity labeling of tubulin with (2-nitro-4-azidophenyl)deacetylcolchicine: direct evidence for two colchicine binding sites. Biochemistry 28:8515-8525
Wolff J, Knipling L, Cahnmann HJ, Palumbo G (1991) Direct photoaffinity labeling of tubulin with colchicine. Proc Natl Acad Sci USA 88:2820-2824
Uppuluri S, Knipling L, Sackett DL, Wolff J (1993) Localization of the colchicine-binding site of tubulin. Proc Natl Acad Sci USA 90:11598-11602
Bourdron J, Barbier P, Allegro D, Villard C, Lafitte D, Commeiras L, Parrain JL, Peyrot V (2009) Caulerpenyne binding to tubulin: structural modifications by a non conventional pharmacological agent. Med Chem 5:182-190
Lafitte D, Lamour V, Tsvetkov PO, Makarov AA, Klich M, Deprez P, Moras D, Briand C, Gilli R (2002) DNA gyrase interaction with coumarin-based inhibitors: the role of the hydroxybenzoate isopentenyl moiety and the 5′-methyl group of the noviose. Biochemistry 41:7217-7223
Verdier-Pinard P, Gares M, Wright M (1999) Differential in vitro association of vinca alkaloid-induced tubulin spiral filaments into aggregated spirals. Biochem Pharmacol 58:959-971
Lobert S, Fahy J, Hill BT, Duflos A, Etievant C, Correia JJ (2000) Vinca alkaloid-induced tubulin spiral formation correlates with cytotoxicity in the leukemic L1210 cell line. Biochemistry 39:12053-12062
Buey RM, Barasoain I, Jackson E, Meyer A, Giannakakou P, Paterson I, Mooberry S, Andreu JM, Díaz JF (2005) Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity. Chem Biol 12:1269-1279
Diaz JF, Menendez M, Andreu JM (1993) Thermodynamics of ligand-induced assembly of tubulin. Biochemistry 32:10067-10077
Na GC, Timasheff SN (1986) Interaction of vinblastine with calf brain tubulin: multiple equilibria. Biochemistry 25:6214-6222
Fahy J, Duflos A, Ribet JP, Jacquesy JC, Berrier C, Jouannetaud MP, Zunino F (1997) Vinca alkaloids in superacidic media: a method for creating a new family of antitumor derivatives. J Am Chem Soc 119:8576-8577 (Pubitemid 27404589)
Bhattacharyya B, Wolff J (1974) Promotion of fluorescence upon binding of colchicine to tubulin. Proc Natl Acad Sci USA 71:2627-2631
Dustin P (1978) Microtubules. Springer, Berlin
Schlesinger N, Schumacher R, Catton M, Maxwell L (2006) Colchicine for acute gout. Cochrane Database Syst Rev 18:CD006190
Lidar M, Livneh A (2007) Familial Mediterranean fever: clinical, molecular and management advancements. Neth J Med 65:318-324 (Pubitemid 350011355)
ter Haar E, Rosenkranz HS, Hamel E, Day BW (1996) Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents. Bioorg Med Chem 4:1659-1671
Sun L, Vasilevich NI, Fuselier JA, Coy DH (2004) Abilities of 3, 4-diarylfuran-2-one analogs of combretastatin A-4 to inhibit both proliferation of tumor cell lines and growth of relevant tumors in nude mice. Anticancer Res 24:179-186 (Pubitemid 38279706)
Hamel E, Lin CM, Flynn E, D'Amato RJ (1996) Interactions of 2-methoxyestradiol, an endogenous mammalian metabolite, with unpolymerized tubulin and with tubulin polymers. Biochemistry 35:1304-1310 (Pubitemid 26050794)
Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, Willard MT, Zhong H, Simons JW, Giannakakou P (2003) 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3:363-375 (Pubitemid 38340305)
Verdier-Pinard P, Sitachitta N, Rossi JV, Sackett DL, Gerwick WH, Hamel E (1999) Biosynthesis of radiolabeled curacin A and its rapid and apparently irreversible binding to the colchicine site of tubulin. Arch Biochem Biophys 370:51-58 (Pubitemid 29476949)
Wipf P, Reeves JT, Day BW (2004) Chemistry and biology of curacin A. Curr Pharm Des 10:1417-1437
Gu L, Wang B, Kulkarni A, Geders TW, Grindberg RV, Gerwick L, Håkansson K, Wipf P, Smith JL, Gerwick WH, Sherman DH (2009) Metamorphic enzyme assembly in polyketide diversification. Nature 459:731-735
Yang CG, Barasoain I, Li X, Matesanz R, Liu R, Sharom FJ, Yin DL, Díaz JF, Fang WS (2007) Overcoming tumor drug resistance with high-affinity taxanes: a SAR study of C2-modified 7-acyl-10-deacetyl cephalomannines. ChemMedChem 2:691-701
Verdier-Pinard P, Kepler JA, Pettit GR, Hamel E (2000) Sustained intracellular retention of dolastatin 10 causes its potent antimitotic activity. Mol Pharmacol 57:180-187 (Pubitemid 30033274)
Hennenfent KL, Govindan R (2006) Novel formulations of taxanes: a review. Old wine in a new bottle? Ann Oncol 17:735-749
Bradley MO, Swindell CS, Anthony FH, Witman PA, Devanesan P, Webb NL, Baker SD, Wolff AC, Donehower RC (2001) Tumor targeting by conjugation of DHA to paclitaxel. J Control Release 74:233-236 (Pubitemid 32727625)
Schuch G (2005) EndoTAG-1. MediGene. Curr Opin Investig Drugs 6:1259-1265
Ibrahim NK, Desai N, Legha S, Soon-Shiong P, Theriault RL, Rivera E, Esmaeli B, Ring SE, Bedikian A, Hortobagyi GN, Eilerhorst JA (2002) Phase I and pharmacokinetic study of ABI007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. Clin Cancer Res 8:1038-1044 (Pubitemid 34517637)
Trieu V, Hwang J, Desai N (2007) Nanoparticle albumin-bound (nab) technology may enhance antitumor activity via targeting of SPARC protein. New targets and delivery system for cancer diagnosis and treatment (SKCC). San Diego, Abstract 53
Faklaris O, Garrot D, Joshi V, Druon F, Boudou JP, Sauvage T, Georges P, Curmi PA, Treussart F (2008) Detection of single photoluminescent diamond nanoparticles in cells and study of the internalization pathway. Small 4:2236-2239
Ciofani G, Riggio C, Raffa V, Menciassi A, Cuschieri A (2009) A bi-modal approach against cancer: magnetic alginate nanoparticles for combined chemotherapy and hyperthermia. Med Hypotheses 73:80-82
Rose WC, Long BH, Fairchild CR, Lee FY, Kadow JF (2001) Preclinical pharmacology of BMS-275183, an orally active taxane. Clin Cancer Res 7:2016-2021
Distefano M, Scambia G, Ferlini C, Gaggini C, De Vincenzo R, Riva A, Bombardelli E, Ojima I, Fattorossi A, Panici PB, Mancuso S (1997) Anti-proliferative activity of a new class of taxanes (14beta-hydroxy-10- deacetylbaccatin III derivatives) on multidrug-resistance-positive human cancer cells. Int J Cancer 72:844-850 (Pubitemid 27431529)
Mooberry SL, Randall-Hlubek DA, Leal RM, Hegde SG, Hubbard RD, Zhang L, Wender PA (2004) Microtubule-stabilizing agents based on designed laulimalide analogues. Proc Natl Acad Sci USA 101:8803-8808 (Pubitemid 38745852)
Shin Y, Fournier JH, Balachandran R, Madiraju C, Raccor BS, Zhu G, Edler MC, Hamel E, Day BW, Curran DP (2005) Synthesis and biological evaluation of (-)-16-normethyldictyostatin: a potent analogue of (-)-dictyostatin. Org Lett 7:2873-2876 (Pubitemid 40992585)
Mooberry SL, Tien G, Hernandez AH, Plubrukam A, Davidson BS (1999) Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents. Cancer Res 59:653-660 (Pubitemid 29076064)
Hill BT (2001) Vinflunine, a second generation novel Vinca Alkaloid with a distinctive pharmacological profile, now in clinical development and prospects for future mitotic blockers. Curr Pharm Des 7:1199-1212
Wen B, Fitch WL (2009) Analytical strategies for the screening and evaluation of chemically reactive drug metabolites. Expert Opin Drug Metab Toxicol 5:39-55
Vahdat L (2008) Ixabepilone: a novel antineoplastic agent with low susceptibility to multiple tumor resistance mechanisms. Oncologist 13:214-221
Zorza G, Van Heugen JC, De Graeve J, Puozzo C (2007) Development of a sensitive liquid chromatography method coupled with a tandem mass spectrometric detection for the clinical analysis of vinflunine and 4-O-deacetyl vinflunine in blood, urine and faeces. J Chromatogr B Analyt Technol Biomed Life Sci 853:294-302 (Pubitemid 46891369)
Kirwan IG, Loadman PM, Swaine DJ, Anthoney DA, Pettit GR, Lippert JW 3rd, Shnyder SD, Cooper PA, Bibby MC (2004) Comparative preclinical pharmacokinetic and metabolic studies of the combretastatin prodrugs combretastatin A4 phosphate and Al phosphate. Clin Cancer Res 10:1446-1453
Dahllof B, Billstrom A, Cabral F, Hartley-Asp B (1993) Estramustine depolymerizes microtubules by binding to tubulin. Cancer Res 53:4573-4581 (Pubitemid 23304382)
Marouga R, David S, Hawkins E (2005) The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem 382:669-678 (Pubitemid 40890994)
Yang YX, Chen ZC, Zhang GY, Yi H, Xiao ZQ (2008) A subcelluar proteomic investigation into vincristine-resistant gastric cancer cell line. J Cell Biochem 104:1010-1021 (Pubitemid 351830847)
Oda Y, Owa T, Sato T, Boucher B, Daniels S, Yamanaka H, Shinohara Y, Yokoi A, Kuromitsu J, Nagasu T (2003) Quantitative chemical proteomics for identifying candidate drug targets. Anal Chem 75:2159-2165 (Pubitemid 36542358)
Chong PK, Gan CS, Pham TK, Wright PC (2006) Isobaric tags for relative and absolute quantitation (iTRAQ) reproducibility: implication of multiple injections. J Proteome Res 5:1232-1240
Ong SE, Foster LJ, Mann M (2003) Mass spectrometric-based approaches in quantitative proteomics. Methods 29:124-130 (Pubitemid 36269199)
Wang G, Wu WW, Zeng W, Chou CL, Shen RF (2006) Labelfree protein quantification using LC-coupled ion trap or FT mass spectrometry: reproducibility, linearity, and application with complex proteomes. J Proteome Res 5:1214-1223 (Pubitemid 43727800)
Zhang J, MacRae TH (1994) Nucleotide dependence and cytoplasmic localization of a 49-kDa microtubule cross-linking protein from the brine shrimp, Artemia. J Biol Chem 269:3053-3062 (Pubitemid 24235815)
Burkhart CA, Kavallaris M, Band Horwitz S (2001) The role of beta-tubulin isotypes in resistance to antimitotic drugs. Biochim Biophys Acta 1471:01-09 (Pubitemid 32146550)
Kavallaris M, Kuo DY, Burkhart CA, Regl DL, Norris MD, Haber M, Horwitz SB (1997) Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific betatubulin isotypes. J Clin Invest 100:1282-1293 (Pubitemid 27386315)
Ranganathan S, Benetatos CA, Colarusso PJ, Dexter DW, Hudes GR (1998) Altered beta-tubulin isotype expression in paclitaxelresistant human prostate carcinoma cells. Br J Cancer 77:562-566 (Pubitemid 28059462)
Liu B, Staren ED, Iwamura T, Appert HE, Howard JM (2001) Mechanisms of taxotere-related drug resistance in pancreatic carcinoma. J Surg Res 99:179-186 (Pubitemid 32703435)
Liu B, Staren E, Iwamura T, Appert H, Howard J (2001) Taxotere resistance in SUIT Taxotere resistance in pancreatic carcinoma cell line SUIT 2 and its sublines. World J Gastroenterol 7:855-859 (Pubitemid 34051507)
Kavallaris M, Tait AS, Walsh BJ, He L, Horwitz SB, Norris MD, Haber M (2001) Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells. Cancer Res 61:5803-5809 (Pubitemid 32769098)
Dumontet C, Jaffrezou JP, Tsuchiya E, Duran GE, Chen G, Derry WB, Wilson L, Jordan MA, Sikic BI (2004) Resistance to microtubule-targeted cytotoxins in a K562 leukemia cell variant associated with altered tubulin expression and polymerization. Bull Cancer 91:E81-E112
Carre M, Andre N, Carles G, Borghi H, Brichese L, Briand C, Braguer D (2002) Tubulin is an inherent component of mitochondrial membranes that interacts with the voltage-dependent anion channel. J Biol Chem 277:33664-33669
Cicchillitti L, Penci R, Di Michele M, Filippetti F, Rotilio D, Donati MB, Scambia G, Ferlini C (2008) Proteomic characterization of cytoskeletal and mitochondrial class III beta-tubulin. Mol Cancer Ther 7:2070-2079
Brun V, Masseion C, Garin J, Dupuis A (2009) Isotope dilution strategies for absolute quantitative proteomics. J Proteomics 72:740-749
Freedman H, Huzil JT, Luchko T, Luduena RF, Tuszynski JA (2009) Identification and characterization of an intermediate taxol binding site within microtubule nanopores and a mechanism for tubulin isotype binding selectivity. J Chem Inf Model 49:424-436
Vassal E, Barette C, Fonrose X, Dupont R, Sans-Soleilhac E, Lafanechère L (2006) Miniaturization and validation of a sensitive multiparametric cell-based assay for the concomitant detection of microtubule-destabilizing and microtubule-stabilizing agents. J Biomol Screen 11:377-389 (Pubitemid 43846338)
Esquenazi E, Coates C, Simmons L, Gonzalez D, Gerwick WH, Dorrestein PC (2008) Visualizing the spatial distribution of secondary metabolites produced by marine cyanobacteria and sponges via MALDI-TOF imaging. Mol Biosyst 4:562-570 (Pubitemid 351706300)
Trim PJ, Henson CM, Avery JL, McEwen A, Snel MF, Claude E, Marshall PS, West A, Princivalle AP, Clench MR (2008) Matrix-assisted laser desorption/ionization-ion mobility separation-mass spectrometry imaging of vinblastine in whole body tissue sections. Anal Chem 80:8628-8634
Luxembourg SL, Mize TH, McDonnell LA, Heeren RM (2004) High-spatial resolution mass spectrometric imaging of peptide and protein distributions on a surface. Anal Chem 76:5339-5344
Piehowski PD, Carado AJ, Kurczy ME, Ostrowski SG, Heien ML, Winograd N, Ewing AG (2008) MS/MS methodology to improve subcellular mapping of cholesterol using TOF-SIMS. Anal Chem 80:8662-8667
Lemaire R, Stauber J, Wisztorski M, Van Camp C, Desmons A, Deschamps M, Proess G, Rudlof I, Woods AS, Day R, Salzet M, Foumier I (2007) Tag-mass: specific molecular imaging of transcriptome and proteome by mass spectrometry based on photocleavable tag. J Proteome Res 6:2057-2067 (Pubitemid 46985093)
Lemaire R, Menguellet SA, Stauber J, Marchaudon V, Lucot JP, Collinet P, Farine MO, Vinatier D, Day R, Ducoroy P, Salzet M, Foumier I (2007) Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the HS proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker. J Proteome Res 6:4127-4134 (Pubitemid 350158491)
Iancu C, Mistry SJ, Arkin S, Wallenstein S, Atweh GF (2001) Effects of stathmin inhibition on the mitotic spindle. J Cell Sci 114:909-916 (Pubitemid 32266262)
Alli E, Bash-Babula J, Yang JM, Hait WN (2002) Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. Cancer Res 62:6864-6869 (Pubitemid 35424074)
Alli E, Yang JM, Ford JM, Hait WN (2007) Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cells. Mol Pharmacol 71:1233-1240 (Pubitemid 46658676)
Mistry SJ, Bank A, Atweh GF (2007) Synergistic antiangiogenic effects of stathmin inhibition and taxol exposure. Mol Cancer Res 5:773-782 (Pubitemid 47294805)
Iancu C, Mistry SJ, Arkin S, Atweh GF (2000) Taxol and antistathmin therapy: a synergistic combination that targets the mitotic spindle. Cancer Res 60:3537-3541 (Pubitemid 30482174)
Pusztai L (2007) Markers predicting clinical benefit in breast cancer from microtubule-targeting agents. Ann Oncol 18(Suppl 12):xii15-20
Martello LA, Verdier-Pinard P, Shen HJ, He L, Torres K, Orr GA, Horwitz SB (2003) Elevated levels of microtubule destabilizing factors in a Taxol-resistant/dependent A549 cell line with an alpha-tubulin mutation. Cancer Res 63:1207-1213 (Pubitemid 36355832)
Gigant B, Curmi PA, Martin-Barbey C, Charbaut E, Lachkar S, Lebeau L, Siavoshian S, Sobel A, Knossow M (2000) The 4 A X-ray structure of a tubulin:stathmin-like domain complex. Cell 102:809-816
Steinmetz MO (2007) Structure and thermodynamics of the tubulin-stathmin interaction. J Struct Biol 158:137-147
Alli E, Yang JM, Hait WN (2007) Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53. Oncogene 26:1003-1012 (Pubitemid 46272214)
King MV, DeVries JL, Pepinsky R (1952) An X-ray diffraction determination of the chemical structure of colchicine. Acta Crystallogr B 5:437
Devred F, Tsvetkov PO, Barbier P, Allegro D, Horwitz SB, Makarov AA, Peyrot V (2008) Stathmin/Op18 is a novel mediator of vinblastine activity. FEBS Lett 582:2484-2488
Su D, Smith SM, Preti M, Schwartz P, Rutherford TJ, Menato G, Danese S, Ma S, Yu H, Katsaros D (2009) Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel. Cancer 115:2453-2463
McGrogan BT, Gilmartin B, Carney DN, McCann A (2008) Taxanes, microtubules and chemoresistant breast cancer. Biochim Biophys Acta 1785:96-132
Peth A, Boettcher JP, Dubiel W (2007) Ubiquitin-dependent proteolysis of the microtubule end-binding protein 1, EB1, is controlled by the COP9 signalosome: possible consequences for microtubule filament stability. J Mol Biol 368:550-563 (Pubitemid 46483494)
Makarov AA, Tsvetkov PO, Villard C, Esquieu D, Pourroy B, Fahy J, Braguer D, Peyrot V, Lafitte D (2007) Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP. Biochemistry 46:14899-14906 (Pubitemid 350308881)
He L, Yang CP, Horwitz SB (2001) Mutations in beta-tubulin map to domains involved in regulation of microtubule stability in epothilone-resistant cell lines. Mol Cancer Ther 1:3-10
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
